Sign in
TerminatedNo phase

Low Intensity Focused Ultrasound for Binge Eating Disorder

Key facts

Who runs it
Ali Rezai
Where
Morgantown, United StatesSee the site
Trial code
Status
Terminated
People taking part
4 people enrolled
Started
31 Oct 2024
Ended
30 Sept 2026
Type of study
Interventional
Treatments tested
  • LIFU Neuromodulation
Record updated
17 November 2026
Why it stopped
poor accrual,

Who can take part

Age
22 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Males and non-pregnant females, 22 - 65 years of age
  • Participant meets DSM-5 criteria for moderate to extreme BED
  • Weight ≤450lb to accommodate in MRI
  • Shoulder width of ≤65 inches to accommodate in MRI
  • The neuromodulation targets are visible on MRI for target selection
  • Participant is able and willing to give informed consent

Who cannot take part

  • Evidence of substance (alcohol or other drug) use disorder during the previous 12 months (assessed via SCID-5)
  • Use of any medications that, in the opinion of the Investigator, may put the participant at higher risk for AEs, or impair the participant's ability to perform complete study procedures
  • Participant is considered to be a poor surgical or study candidate, which may include, but is not limited to the following: any medical, social, or psychological problem that could complicate the required procedures and evaluations of the study in the judgment of the investigator
  • Unable to undergo MR-imaging because of implanted pacemakers, medication pumps, aneurysm clips, metallic prostheses (including metal pins and rods, heart valves or cochlear implants), shrapnel fragments, permanent make-up or small metal fragments in the eye that welders and other metal workers may have, or if candidates are uncomfortable in small spaces (have claustrophobia)
  • Participants with more than 30% of the skull area traversed by the sonication pathway are covered by scars, scalp disorders (e.g., eczema), atrophy of the scalp, or implanted objects in the skull or the brain
  • Participants with known untreated or unstable cardiac status or hypertension
  • Past or present diagnosis of schizophrenia, psychotic disorder or bipolar disorder (assessed via SCID-5)
  • Participant who is currently participating in another clinical investigation with an active treatment arm
  • Participant is pregnant/lactating or planning to be pregnant

Where in United States

  • West Virginia University Rockefeller Neuroscience InstituteMorgantown, United States

About the trial

What the trial wants to find out

This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)

The group in the trial

  • LIFU NeuromodulationTreatment being tested

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Binge Eating Disorder (BED)
Record updated
17 November 2026